Skip to content
value.today

Biodel Inc

Total raised
$19 M
1 round on record
Latest round
$19 M
Jun 2012
First round on record
Jun 2012
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Biodel Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2012$19 MNo. 1$10 to $50 million

Biodel Inc: Raise no. 1, Jun 2012

Investors in this round

19 investors had bought by the notice of Jun 29, 2012: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,110,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan S. Krasner · Executive Officer
  • Erik S. Steiner · Executive Officer
  • Errol B. De Souza · Executive Officer, Director
  • Gerard J. Michel · Executive Officer
  • Paul S. Bavier · Executive Officer
  • Barry S. Ginsberg · Director
  • Brian J.G. Pereira · Director
  • Daniel W. Lorber · Director
  • Davey S. Scoon · Director
  • Ira W. Lieberman · Director
  • Julie R. Brown · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • JMP Securities LLC (CRD 22208) · San Francisco, CaliforniaSold in all US states
  • William Blair & Company L.L.C. (CRD 1252) · Chicago, IllinoisSold in all US states

Signed by Paul Bavier, General Counsel. Source: SEC Form D, newest notice filed Jun 29, 2012. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Biodel Inc chose not to state its revenue in its newest notice of a funding round (Jun 2012).

    SEC Form D · Jun 2012

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jun 2012

That is all the official record says: Biodel Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Biodel Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Biodel Inc
NameRoleNamed in
Alan S. KrasnerExecutive officerJun 2012
Erik S. SteinerExecutive officerJun 2012
Errol B. De SouzaExecutive officerJun 2012
Gerard J. MichelExecutive officerJun 2012
Paul S. BavierExecutive officerJun 2012
Barry S. GinsbergDirectorJun 2012
Brian J.G. PereiraDirectorJun 2012
Daniel W. LorberDirectorJun 2012
Davey S. ScoonDirectorJun 2012
Errol B. De SouzaDirectorJun 2012
Ira W. LiebermanDirectorJun 2012
Julie R. BrownDirectorJun 2012